NeoGenomics BRCA1/2, Lynch Syndrome Testing Services

NeoGenomics has launched a new line of germline cancer predisposition testing services, including comprehensive testing for BRCA1/2 encompassing the analysis of all exons and adjacent intronic regions. Additionally, the firm launched germline testing for Lynch syndrome, which includes a comprehensive analysis for point mutations, indels, and large deletions in MLH1, MSH2, EPCAM, MSH6, and PMS2 genes.